leading brands of glp-1 agonists in biopharma GLP Agonist Clinical Trial Pipeline Appears Robust With 20+ GLP-1 2.0: Where the Next

11 Importantly, structural modifications to GLP-1RAs can prolong their half-life to 5-7 days compared to the 1-5 minute long half-life of endogenous GLP-1

Ultimately, investors increased Eli Lilly's market capitalization by around $95 billion in one day after these results

It has also been shown that it can influence the proliferation and survival of cells and has a certain effect on the prognosis of some neoplastic diseases

doi:10.3389/fncel.2023.1156829 9

Plus, it stops the production of glucagon , thus decreasing glucose from the liver

Many in vivo and in vitro studies make use of Ex-4, a well-known orthosteric antagonist for the GLP-1R [27]